If investors in China's biotech industry needed one more sign that the sector is coming of age, then a major licensing deal RemeGen Co Ltd (9995.HK) struck last month with Seattle-based Seagen Inc fits the bill.
Analysis-China s biotech sector comes of age with big licensing deals, global ambitions netscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from netscape.com Daily Mail and Mail on Sunday newspapers.
(NAPSI)—There’s good news, bad news and better news about combating cancer in America these days.The good news is there’s been an overall decline in U.S. cancer deaths since 1991.The bad